Free Trial

Silicon Laboratories (NASDAQ:SLAB) Hits New 52-Week Low - Should You Sell?

Silicon Laboratories logo with Computer and Technology background
Remove Ads

Silicon Laboratories Inc. (NASDAQ:SLAB - Get Free Report)'s share price reached a new 52-week low during trading on Thursday . The stock traded as low as $82.82 and last traded at $99.41, with a volume of 1632038 shares. The stock had previously closed at $86.17.

Analysts Set New Price Targets

SLAB has been the topic of a number of analyst reports. StockNews.com cut shares of Silicon Laboratories from a "hold" rating to a "sell" rating in a report on Thursday, March 27th. Susquehanna assumed coverage on shares of Silicon Laboratories in a research note on Tuesday, December 17th. They issued a "neutral" rating and a $130.00 price target on the stock. KeyCorp increased their price objective on Silicon Laboratories from $115.00 to $160.00 and gave the stock an "overweight" rating in a report on Wednesday, January 22nd. Stifel Nicolaus raised their target price on Silicon Laboratories from $135.00 to $145.00 and gave the company a "buy" rating in a research report on Monday, January 6th. Finally, Needham & Company LLC reiterated a "buy" rating and set a $150.00 price target on shares of Silicon Laboratories in a research report on Wednesday, March 12th. One analyst has rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $136.20.

Read Our Latest Stock Report on SLAB

Remove Ads

Silicon Laboratories Price Performance

The company has a fifty day moving average price of $126.42 and a two-hundred day moving average price of $122.32. The firm has a market cap of $2.97 billion, a price-to-earnings ratio of -15.41 and a beta of 1.33.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last posted its quarterly earnings data on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share for the quarter, meeting the consensus estimate of ($0.11). The company had revenue of $166.25 million during the quarter, compared to analyst estimates of $166.09 million. Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The business's revenue for the quarter was up 91.4% on a year-over-year basis. During the same quarter last year, the firm posted ($1.19) EPS. On average, research analysts expect that Silicon Laboratories Inc. will post -0.97 earnings per share for the current fiscal year.

Insider Buying and Selling at Silicon Laboratories

In other news, Director Navdeep S. Sooch sold 2,360 shares of the business's stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total transaction of $351,640.00. Following the sale, the director now owns 400,567 shares in the company, valued at $59,684,483. The trade was a 0.59 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William G. Bock sold 1,000 shares of the firm's stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $149.43, for a total transaction of $149,430.00. Following the completion of the transaction, the director now directly owns 31,115 shares of the company's stock, valued at $4,649,514.45. This represents a 3.11 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 5,360 shares of company stock valued at $782,610. Corporate insiders own 1.60% of the company's stock.

Institutional Trading of Silicon Laboratories

Hedge funds have recently modified their holdings of the business. Capital Research Global Investors raised its position in Silicon Laboratories by 23.3% during the fourth quarter. Capital Research Global Investors now owns 2,131,920 shares of the semiconductor company's stock valued at $264,827,000 after buying an additional 403,010 shares during the period. Norges Bank purchased a new position in Silicon Laboratories during the 4th quarter valued at about $34,622,000. Invesco Ltd. increased its holdings in shares of Silicon Laboratories by 46.9% in the 4th quarter. Invesco Ltd. now owns 595,382 shares of the semiconductor company's stock valued at $73,958,000 after purchasing an additional 190,085 shares during the period. GAMMA Investing LLC lifted its position in shares of Silicon Laboratories by 22,374.1% in the first quarter. GAMMA Investing LLC now owns 126,754 shares of the semiconductor company's stock worth $14,269,000 after purchasing an additional 126,190 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in shares of Silicon Laboratories during the fourth quarter worth approximately $14,252,000.

Silicon Laboratories Company Profile

(Get Free Report)

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.

Recommended Stories

Should You Invest $1,000 in Silicon Laboratories Right Now?

Before you consider Silicon Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.

While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads